Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Palantir Erupts On Big Earnings Beat; Next Phase Of AI Is Application Layer

% of readers think this story is Fact. Add your two cents.


Palantir Erupts On Big Earnings Beat; Next Phase Of AI Is Application Layer

First came advanced Nividia chips, followed by the “Powering Up America” theme and a surge in data center investments. So what’s next? The focus shifts to the application layer. 

Now that Deepseek AI is behind us, investors are beginning to focus on the software application layer that may further the AI bubble. 

Take Palantir Technologies, for example. Shares surged Monday evening after the AI software company delivered a strong fourth-quarter beat, issued a full-year revenue forecast above Bloomberg Consensus, and its CEO touted “untamed organic growth” for its AI products. 

Palantir CEO Alex Karp

Palantir is best known for its national security work, providing the US government and federal agencies, including the Department of Defense, with high-tech AI products. The company reported a massive fourth-quarter revenue beat, up 36% to $827.5 million, surpassing the Bloomberg-tracked average consensus of $775.9 million. Profit also exceeded expectations, coming in at 14 cents per share, compared with an estimated 11 cents. 

Here’s a snapshot of fourth-quarter results (courtesy of Bloomberg): 

  • Revenue $827.5 million, +36% y/y, estimate $775.9 million

  • Operating profit $11.0 million, -83% y/y, estimate $84.8 million

  • EPS 3.0c vs. 4.0c y/y

  • Cash and cash equivalents $2.10 billion vs. $831.0 million y/y, estimate $1.18 billion

  • Adjusted operating profit $372.5 million, +78% y/y, estimate $309.6 million

  • Adjusted EPS 14c vs. 8.0c y/y, estimate 11c

  • Adjusted Ebitda $379.5 million, +75% y/y, estimate $314.3 million

  • Adjusted free cash flow $517.4 million, +70% y/y

  • Adjusted operating margin 45% vs. 34% y/y, estimate 39.6%

The Denver-based company reported a 2025 full-year forecast that exceeded the Bloomberg Consensus estimates as it rides the next evolution of the AI bubble, that being the application layer… 

Full-Year Forecast (courtesy of Bloomberg): 

  • Sees revenue $3.74 billion to $3.76 billion, estimate $3.54 billion

  • Sees adjusted operating profit $1.55 billion to $1.57 billion, estimate $1.37 billion

  • Sees adjusted free cash flow $1.5 billion to $1.7 billion

  • Sees US Commercial revenue above $1.08 billion

First Quarter Forecast: 

  • Sees revenue $858 million to $862 million, estimate $802.9 million (Bloomberg Consensus)

  • Sees adjusted operating profit $354 million to $358 million, estimate $300.4 million

Here’s what Wall Street had to say (courtesy of Bloomberg):

Morgan Stanley analyst Sanjit Singh (raised to equal-weight from underweight)

  • Palantir’s fundamentals are getting better and there’s a lack of a clear downside catalyst despite the stock’s expensive valuation

  • Results were driven by demand in the company’s US commercial and US government units

  • PT set to $95 from $60, new target implies a 13% increase from last close

Bloomberg Intelligence analyst Mandeep Singh

  • While sales gains outside the US may remain muted, Palantir’s strong 4Q government segment growth could be the result of increased geopolitical tensions

  • “International’s contribution to total sales may decline by at least 10 percentage points”

Jefferies analyst Brent Thill (underperform, PT to $60 from $28)

  • Palantir reported an exceptional 4Q “with a record rev beat, growth acceleration across most top-line metrics”

  • “Fundamentals have been strong and we are constructive on the accelerating US momentum”

William Blair (underperform)

  • The outlook “was a shortfall of $750 million from when CEO Alex Karp stated, ‘I am driving the company to get to $4.5 billion in 2025,’” on an August 2022 earnings call

  • “Although the company missed its three-year target, the company’s Foundry and Gotham software is experiencing significant momentum in the market”

  • Shares trade at “a $100 billion-plus premium to peers with similar fundamentals”

RBC Capital Markets (underperform, PT $11)

  • “Palantir reported a solid quarter, and 2025 guidance came in ahead of consensus”

  • The acceleration in US commercial growth is notable

Vital Knowledge

  • The results show “solid upside” on sales and operating margins

  • The outlook is positive and the company’s commentary “remains as bullish as ever”

Shares of Palantir surged 21% in premarket trading in New York, reaching a new record high of $101 per share.

Back to the broader view, Goldman’s Kash Rangan explained to clients this week that “the Application layer of AI development is poised to benefit in CY25 as revenue shifts from the Infrastructure layer.” 

And we’ll end the note with Palantir CTO Shyam Sankar’s comments on China…

. . .

Tyler Durden Tue, 02/04/2025 – 08:05


Source: https://freedombunker.com/2025/02/04/palantir-erupts-on-big-earnings-beat-next-phase-of-ai-is-application-layer/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.